Business Context and Reporting Period
This Form 8-K Current Report was filed by NewAmsterdam Pharma Company N.V. on April 20, 2026. The report discloses a material corporate governance event regarding the departure of a senior officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation and separation terms rather than financial performance.
Material Changes
The primary material change is the departure of Louise Kooij, the Company's Chief Accounting Officer. Her employment is set to end effective August 31, 2026. A Separation Agreement was executed on April 24, 2026, outlining the terms of her exit.
Outlook, Risks, and Unusual Items
Separation Terms:
- Severance: A lump sum payment equal to twelve months of base salary.
- Bonus: A pro-rated 2026 annual cash bonus based on target achievement through the separation date.
- Accrued Time: Payment for accrued but unused holiday and vacation days in accordance with Dutch law.
- Equity: Extension of vesting for outstanding stock options and RSUs through January 10, 2027. The exercise period for vested options will expire on February 10, 2027.
Covenants: The agreement includes restrictive covenants regarding confidentiality, non-compete, and non-disparagement, along with a release of claims.
Future Filings: The full Separation Agreement is intended to be filed as an exhibit to the Quarterly Report on Form 10-Q for the quarter ending June 30, 2026.
Investor Verification Checklist
- Verify the exact base salary amount to calculate the specific lump sum severance liability.
- Review the upcoming Form 10-Q (due after June 30, 2026) for the full text of the Separation Agreement.
- Assess the impact of the Chief Accounting Officer's departure on the company's internal controls and financial reporting timeline.
- Confirm the number of outstanding stock options and RSUs held by the departing officer to evaluate potential dilution or expense recognition.